• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Recall: FDA puts highest-risk label on Respironics’ V60 ventilators

Recall: FDA puts highest-risk label on Respironics’ V60 ventilators

June 25, 2013 By Arezu Sarvestani

Philips Respironics logo

California-based Respironics, a subsidiary of technology giant Philips (NYSE:PHG), announced today that the FDA slapped its highest-risk label on a recall that affects more than 19,000 units of Respironics’ V60 ventilators.

The V60 devices are assist ventilators used to augment breathing in the hospital or at home for patients with respiratory failure, chronic respiratory insufficiency, or obstructive sleep apnea. The federal watchdog agency gave the recall Class I status, defined as a "situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death."

Respironics recalled its V60 ventilators after discovering an issue with the their power management software. The devices may shut down suddenly and cease the flow of ventilator support to a patient, possibly without sounding an alarm.

Respironics initiated the recall on June 4 and was notified of the FDA’s Class I status on June 17, according to a company statement. The device maker said it has already developed a fix and has issued a warning to all distributors, providers, sales personnel and customers that may need the updated software.

This is the 2nd recall affecting the V60 devices. Respironics late last year recalled 116 ventilators after receiving reports of 2 motor failures in the V60 line. Respironics said at the time that the recall was prompted by an issue in the ventilators’ blower assembly.

The FDA’s decision also marks the company’s 2nd Class I recall in as many years, following January 2012’s recall of the Trilogy 100 ventilators for manufacturing issues that the FDA said could result in patient injury or death.

Filed Under: News Well, Recalls, Respiratory, Software / IT Tagged With: Philips, Respironics Inc.

More recent news

  • Breaking: Sequel to launch twiist automated insulin delivery system next month
  • Dexcom shares U.S. report on CGM benefits for type 2 diabetes
  • Data backs Medtronic MiniMed 780G for type 2, children as company seeks expanded indications
  • Endogenex data supports type 2 diabetes procedure
  • Ambu wins FDA clearance for first single-use cysto-nephroscope

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy